✦ LIBER ✦
1417 POSTER A Phase II Trial of Afatinib (BIBW 2992) in Patients With Tumours Prospectively Screened for EGFR And/or HER2 Gene Amplification or EGFR Activating Mutations
✍ Scribed by E.L. Kwak; G.I. Shapiro; S.M. Cohen; C.R. Becerra; H.J. Lenz; S. Gooden; M. Robohn; F. Le-Maulf; V.K. Chand; A.J. lafrate
- Book ID
- 117661403
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 43 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.